Validation of Roche LightCycler Epstein-Barr virus quantification reagents in a clinical laboratory setting

Journal of Molecular Diagnostics

Volumn 8, Issue 5, 2006, Pages 589-597

  Gulley, Margaret L ^a,b   Fan, Hongxin ^a,c   Elmore, Sandra H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LATENT MEMBRANE PROTEIN 2; NAKED DNA; VIRUS DNA;

ARTICLE; CANCER CELL; CELL LINE; CLINICAL LABORATORY; DIAGNOSTIC ACCURACY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; INFECTIOUS MONONUCLEOSIS; LYMPHOPROLIFERATIVE DISEASE; NASOPHARYNX CANCER; NONHUMAN; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; VIRUS DETECTION; VIRUS GENOME; VIRUS LOAD; VIRUS SHEDDING;

HUMAN HERPESVIRUS 4;

EID: 33751164659     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2006.050152     Document Type: Article

References (30)

1. Ryan JL, Fan H, Swinnen LJ, Schichman SA, Raab-Traub N, Covington M, Elmore S, Gulley ML: Epstein-Barr Virus (EBV) DNA in plasma is not encapsidated in patients with EBV-related malignancies. Diagn Mol Pathol 2004, 13:61-68
2. Fafi-Kremer S, Morand P, Brion JP, Pavese P, Baccard M, Germi R, Genoulaz O, Nicod S, Jolivet M, Ruigrok RW, Stahl JP, Seigneurin JM: Long-term shedding of infectious epstein-barr virus after infectious mononucleosis. J Infect Dis 2005, 191:985-989
3. Balfour Jr HH, Holman CJ, Hokanson KM, Lelonek MM, Giesbrecht JE, White DR, Schmeling DO, Webb CH, Cavert W, Wang DH, Brundage RC: A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis. J Infect Dis 2005, 192:1505-1512
4. Maurmann S, Fricke L, Wagner HJ, Schlenke P, Hennig H, Steinhoff J, Jabs WJ: Molecular parameters for precise diagnosis of asymptomatic epstein-barr virus reactivation in healthy carriers. J Clin Microbiol 2003, 41:5419-5428
5. Fan H, Gulley ML: Epstein-Barr viral load measurement as a marker of EBV-related disease, Mol Diagn 2001, 6:279-289
6. Gulley ML: Molecular diagnosis of Epstein-Barr virus-related diseases. J Mol Diagn 2001, 3:1-10
7. Lit LC, Chan KC, Leung SF, Lei KI, Chan LY, Chow KC, Chan AT, Lo YM: Distribution of cell-free and cell-associated Epstein-Barr virus (EBV) DNA in the blood of patients with nasopharyngeal carcinoma and EBV-associated lymphoma. Clin Chem 2004, 50:1842-1845
8. Au WY, Pang A, Choy C, Chim CS, Kwong YL: Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immuno-competent patients. Blood 2004, 104:243-249
9. Allen UD, Farkas G, Hebert D, Weitzman S, Stephens D, Petric M, Tellier R, Ngan B, Fecteau A, West L, Wasty S: Risk factors for post-transplant lymphoproliferative disorder in pediatric patients: a case-control study. Pediatr Transplant 2005, 9:450-455
10. Lee TC, Savoldo B, Rooney CM, Heslop HE, Gee AP, Caldwell Y, Barshes NR, Scott JD, Bristow LJ, O'Mahony CA, Goss JA: Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients. Am J Transplant 2005, 5:2222-2228
11. Greenfield HM, Gharib MI, Tumer AJ, Gulver M, Carr T, Will AM, Wynn RF: The impact of monitoring Epstein-Barr virus PCR in paediatric bone marrow transplant patients: Can it successfully predict outcome and guide intervention? Pediatr Blood Cancer 2006, 47:200-205
12. Leung SF, Chan AT, Zee B, Ma B, Chan LY, Johnson PJ, Lo YM: Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type. Cancer 2003, 98:288-291
13. Kalpoe JS, Douwes Dekker PB, van Krieken JH, Baatenburg de Jong RJ, Kroes AC: The role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma (NPC) patients in a low risk population. J Clin Pathol 2006, 59:537-541
14. Fan H, Kim SC, Chima CO, Israel BF, Lawless KM, Eagan PA, Elmore S, Moore DT, Schichman SA, Swinnen LJ, Gulley ML: Epstein-Barr viral load as a marker of lymphoma in AIDS patients. J Med Virol 2005, 75:59-69
15. Bauer CC, Aberle SW, Popow-Kraupp T, Kapitan M, Hofmann H, Puchhammer-Stockl E: Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection. J Med Virol 2005, 75:54-58
16. Chan KC, Zhang J, Chan AT, Lei KI, Leung SF, Chan LY, Chow KC, Lo YM: Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer Res 2003, 63:2028-2032
17. Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX: Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Cancer 2004, 100:1162-1170
18. Wang WY, Chien YC, Jan JS, Chueh CM, Lin JC: Consistent sequence variation of Epstein-Barr virus nuclear antigen 1 in primary tumor and peripheral blood cells of patients with nasopharyngeal carcinoma. Clin Cancer Res 2002, 8:2586-2590
19. Tierney RJ, Edwards RH, Sitki-Green D, Croom-Carter D, Roy S, Yao QY, Raab-Traub N, Rickinson AB: Multiple Epstein-Barr virus strains in patients with infectious mononucleosis: comparison of ex vivo samples with in vitro isolates by use of heteroduplex tracking assays. J Infect Dis 2006, 193:287-297
20. Edwards RH, Sitki-Green D, Moore DT, Raab-Traub N: Potential selection of LMP1 variants in nasopharyngeal carcinoma. J Virol 2004, 78:868-881
21. Leung E, Shenton BK, Green K, Jackson G, Gould FK, Yap C, Talbot D: Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler. Transpl Infect Dis 2004, 6:156-164
22. Jebbink J, Bai X, Rogers BB, Dawson DB, Scheuermann RH, Domiati-Saad R: Development of real-time PCR assays for the quantitative detection of Epstein-Barr virus and cytomegalovirus, comparison of TaqMan probes, and molecular beacons. J Mol Diagn 2003, 5:15-20
23. Ruiz G, Pena P, de Ory F, Echevarria JE: Comparison of commercial real-time PCR assays for quantification of Epstein-Barr virus DNA. J Clin Microbiol 2005, 43:2053-2057
24. Le QT, Jones CD, Yau TK, Shirazi HA, Wong PH, Thomas EN, Patterson BK, Lee AW, Zehnder JL: A comparison study of different PCR assays in measuring circulating plasma epstein-barr virus DNA levels in patients with nasopharyngeal carcinoma. Clin Cancer Res 2005, 11:5700-5707
25. Ryan JL, Fan H, Glaser SL, Schichman SA, Raab-Traub N, Gulley ML: Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma. J Mol Diagn 2004, 6:378-385
26. Matsuo T, Heller M, Petti L, O'Shiro E, Kieff E: Persistence of the entire Epstein-Barr virus genome integrated into human lymphocyte DNA. Science 1984, 226:1322-1325
27. Swinnen LJ, Gulley ML, Hamilton E, Schichman SA: EBV DNA quantitation in serum is highly correlated with the development and regression of post-transplant lymphoproliferative disorder (PTLD) in solid organ transplant recipients. Blood 1998, 92(Suppl 1):314a
28. Stevens SJ, Verkuijlen SA, Hariwiyanto B, Harijadi, Fachiroh J, Paramita DK, Tan IB, Haryana SM, Middeldorp JM: Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia. J Clin Microbiol 2005, 43:3066-3073
29. Bossolasco S, Cinque P, Ponzoni M, Vigano MG, Lazzarin A, Linde A, Falk KI: Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma. J Neurovirol 2002, 8:432-438
30. Ivers LC, Kim AY, Sax PE: Predictive value of polymerase chain reaction of cerebrospinal fluid for detection of Epstein-Barr virus to establish the diagnosis of HIV-related primary central nervous system lymphoma. Clin Infect Dis 2004, 38:1629-1632